Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by enabling the immune system to recognize and attack tumor cells with...

A groundbreaking study conducted by researchers at the Ribeirão Preto Blood Center and the Center for Cell-Based Therapy (CTC) at...

In a groundbreaking publication appearing in Volume 13 of the journal Oncoscience, researchers from the University of Missouri-Columbia present an...

A groundbreaking study led by researchers from Uppsala University and Karolinska Institutet has delivered promising evidence that colorectal cancer screening...

A groundbreaking study published in the distinguished journal Genes & Diseases reveals a critical regulatory mechanism driving breast cancer progression,...

In a groundbreaking study recently published in Genes & Diseases, researchers from Jilin University have unveiled a pivotal mechanism controlling...

Glioblastoma stands as one of the most devastating and treatment-resistant forms of brain cancer, characterized by rapid proliferation and aggressive...

In a groundbreaking discovery poised to reshape the landscape of lung cancer treatment, researchers at Mayo Clinic have elucidated a...

In a groundbreaking advancement that promises to transform therapeutic strategies for muscle-invasive bladder cancer (MIBC), researchers at the Icahn School...

Dr. James R. Downing, MD, the distinguished president and CEO of St. Jude Children's Research Hospital, has announced his planned...